Abiomed Impella RP System Linked To Increased Risk Of Patient Deaths, FDA Warns
The FDA warns that the Abiomed Impella RP System has a higher rate of mortality among patients than its initial clinical trials predicted, potentially because the manufacturer did not take into account many real-world factors affecting patients.…